Plaque Composition and Clinical Outcomes in Acute Coronary Syndrome Patients With Metabolic Syndrome or Diabetes — Steven P. Marso (2012) | RDL Network
Plaque Composition and Clinical Outcomes in Acute Coronary Syndrome Patients With Metabolic Syndrome or Diabetes
JACC. Cardiovascular imaging 5(3): S42-S52
Article 2012 English
Authors
SM
Steven P. Marso
NM
Nestor Mercado
AM
Akiko Maehara
Abstract
2 min read
Objectives
The goal of this study was to characterize the extent and composition of coronary atherosclerosis in patients with diabetes mellitus or the metabolic syndrome (Met Syn) presenting with acute coronary syndromes (ACS).
Background
Diabetes and Met Syn patients have increased rates of major adverse cardiac events (MACE), yet a systematic description of nonculprit lesions for these high-risk groups is incomplete.
Methods
In the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study, ACS patients underwent 3-vessel quantitative coronary angiography, grayscale, and radiofrequency intravascular ultrasound after successful percutaneous coronary intervention (PCI). Subsequent MACE (cardiac death or arrest, myocardial infarction, or rehospitalization for unstable or progressive angina) were adjudicated to the originally treated culprit versus untreated nonculprit lesions in 3 patient groups: 1) diabetes; 2) Met Syn; and 3) neither. Median length of follow-up was 3.4 years.
Results
Of 673 patients, 119 (17.7%) had diabetes and 239 (35.5%) had Met Syn. The cumulative 3-year MACE rate was 29.4% in patients with diabetes, 21.3% with Met Syn, and 17.4% with neither (p = 0.03). MACE adjudicated to untreated nonculprit lesions occurred in 18.7%, 11.7%, and 9.7% of patients, respectively (p = 0.06). Nonculprit lesions in diabetes and Met Syn patients were longer and had greater plaque burden, smaller lumen areas, with greater necrotic core and calcium content. Diabetes and Met Syn patients with future MACE had greater necrotic core and calcification compared with the normal cardiometabolic group.
Conclusions
In this PCI ACS population, patients with diabetes and Met Syn had higher 3-year MACE rates. Lesion length, plaque burden, necrotic core, and calcium content were significantly greater among nonculprit lesions of patients with diabetes and Met Syn, but only necrotic core and calcium were significantly greater in the nonculprit lesions of patients with a future MACE in this exploratory analysis.
John McPherson, Akiko Maehara, Giora Weisz, Gary S. Mintz, Ecaterina Cristea, Roxana Mehran, Michael Foster, Stefan Verheye, LeRoy E. Rabbani, Ke Xu, Martin Fahy, Barry Templin, Zhen Zhang, Alexandra J. Lansky, Bernard De Bruyne, Patrick W. Serruys, Gregg W. Stone
Usman Baber, Gregg W. Stone, Giora Weisz, Pedro R. Moreno, George Dangas, Akiko Maehara, Gary S. Mintz, Ecaterina Cristea, Martin Fahy, Ke Xu, Alexandra J. Lansky, Bertil Wennerblom, Detlef G. Mathey, Barry Templin, Zhen Zhang, Patrick W. Serruys, Roxana Mehran
Alexandra J. Lansky, Vivian G. Ng, Akiko Maehara, Giora Weisz, Amir Lerman, Gary S. Mintz, Bernard De Bruyne, Naim Farhat, Gary S. Niess, Ivana Jankovic, Dana Lazar, Ke Xu, Martin Fahy, Patrick W. Serruys, Gregg W. Stone
Juan Ruiz-García, Amir Lerman, Giora Weisz, Akiko Maehara, Gary S. Mintz, Martin Fahy, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Tony Farah, Rui Campante Teles, Hans Erik Bøtker, Barry Templin, Zhen Zhang, Bernard De Bruyne, Patrick W. Serruys, Gregg W. Stone
Yong Xie, Gary S. Mintz, Junqing Yang, Hiroshi Doi, Andrés Íñiguez, George Dangas, Patrick W. Serruys, John McPherson, Bertil Wennerblom, Ke Xu, Giora Weisz, Gregg W. Stone, Akiko Maehara
Discussion(0)
No comments yet. Be the first to comment.